Lisinopril
- Product NDC
- 51655-292
- 11-digit product format
- 516550292
- Labeler code
- 51655
- Product ID
- 51655-292_d47908e0-635d-3320-e053-2995a90a6c22
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northwind Pharmaceuticals
- Application
- ANDA076059
- Marketing category
- ANDA
- Marketing start
- 2015-03-10
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL
- Active strength
- 40 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51655-292 | LISINOPRIL TABLET [NORTHWIND PHARMACEUTICALS] | 3 | Legacy NDC | 20220101_f9afa965-98c4-48a3-84d5-1fb8f870fe77.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51655-292-26 | 51655029226 | 90 TABLET in 1 BOTTLE, DISPENSING (51655-292-26) | 90 tablet | 2015-03-10 | 0000-00-00 | No | No | Current |
| 51655-292-52 | 51655029252 | 30 TABLET in 1 BOTTLE, DISPENSING (51655-292-52) | 30 tablet | 2020-04-09 | 0000-00-00 | No | No | Current |